GEODE CAPITAL MANAGEMENT, LLC - STOKE THERAPEUTICS INC ownership

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 72 filers reported holding STOKE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of STOKE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,329,283
-63.5%
591,117
-1.4%
0.00%
-100.0%
Q2 2023$6,375,661
+57.3%
599,780
+23.2%
0.00%0.0%
Q1 2023$4,054,044
+92521.5%
486,680
+2.6%
0.00%0.0%
Q4 2022$4,377
-99.9%
474,224
+3.0%
0.00%0.0%
Q3 2022$5,909,000
+0.8%
460,255
+3.7%
0.00%0.0%
Q2 2022$5,862,000
-36.1%
443,809
+1.8%
0.00%0.0%
Q1 2022$9,172,000
+1.7%
435,771
+15.8%
0.00%0.0%
Q4 2021$9,023,000
-2.4%
376,154
+3.5%
0.00%0.0%
Q3 2021$9,243,000
-22.9%
363,335
+2.0%
0.00%
-50.0%
Q2 2021$11,991,000
+5.4%
356,246
+21.6%
0.00%0.0%
Q1 2021$11,381,000
-32.2%
293,036
+8.1%
0.00%
-33.3%
Q4 2020$16,793,000
+148.0%
271,165
+34.1%
0.00%
+200.0%
Q3 2020$6,771,000
+77.7%
202,189
+26.4%
0.00%0.0%
Q2 2020$3,811,000
-10.5%
159,944
-13.9%
0.00%0.0%
Q1 2020$4,256,000
-37.2%
185,856
-22.4%
0.00%0.0%
Q4 2019$6,780,000
+179.8%
239,434
+112.4%
0.00%0.0%
Q3 2019$2,423,000112,7520.00%
Other shareholders
STOKE THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 296,822$7,551,0001.86%
RTW INVESTMENTS, LP 3,644,248$92,710,0001.40%
Cormorant Asset Management, LP 1,278,276$32,519,0001.32%
Redmile Group, LLC 2,381,958$60,597,0001.06%
HighVista Strategies LLC 47,594$1,211,0000.80%
Birchview Capital, LP 15,000$382,0000.26%
GILDER GAGNON HOWE & CO LLC 1,123,355$28,578,0000.15%
Artal Group S.A. 250,000$6,360,0000.14%
Tekla Capital Management LLC 99,263$2,525,0000.08%
Casdin Capital, LLC 120,000$3,053,0000.08%
View complete list of STOKE THERAPEUTICS INC shareholders